Embla Medical hf. (CPH:EMBLA)
29.10
+1.00 (3.56%)
At close: Apr 1, 2025
Embla Medical Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 12,420 | 15,199 | 11,537 | 14,096 | 17,859 | 20,445 | Upgrade
|
Market Cap Growth | 31.74% | 31.74% | -18.15% | -21.07% | -12.65% | -7.38% | Upgrade
|
Enterprise Value | 15,425 | 18,292 | 14,270 | 17,043 | 20,367 | 22,520 | Upgrade
|
Last Close Price | 29.10 | 35.60 | 27.45 | 33.55 | 42.30 | 48.45 | Upgrade
|
PE Ratio | 25.24 | 30.90 | 29.30 | 47.64 | 42.69 | 540.70 | Upgrade
|
Forward PE | 19.80 | 23.84 | 22.12 | 26.05 | 32.70 | 48.07 | Upgrade
|
PS Ratio | 2.02 | 2.47 | 2.18 | 2.82 | 3.80 | 5.34 | Upgrade
|
PB Ratio | 2.22 | 2.70 | 2.43 | 3.19 | 4.36 | 5.82 | Upgrade
|
P/FCF Ratio | 19.37 | 23.70 | 26.29 | 45.80 | 32.69 | 42.82 | Upgrade
|
P/OCF Ratio | 18.18 | 18.18 | 18.14 | 33.33 | 27.17 | 36.42 | Upgrade
|
PEG Ratio | 0.90 | 2.02 | 0.58 | 1.18 | 4.05 | 4.05 | Upgrade
|
EV/Sales Ratio | 2.50 | 2.97 | 2.69 | 3.41 | 4.34 | 5.88 | Upgrade
|
EV/EBITDA Ratio | 12.86 | 18.41 | 19.54 | 27.37 | 25.99 | 48.06 | Upgrade
|
EV/EBIT Ratio | 18.29 | 22.32 | 24.20 | 36.47 | 32.58 | 69.48 | Upgrade
|
EV/FCF Ratio | 24.05 | 28.52 | 32.51 | 55.37 | 37.28 | 47.16 | Upgrade
|
Debt / Equity Ratio | 0.64 | 0.64 | 0.66 | 0.76 | 0.72 | 0.84 | Upgrade
|
Debt / EBITDA Ratio | 3.06 | 3.06 | 3.58 | 4.35 | 3.17 | 5.06 | Upgrade
|
Debt / FCF Ratio | 5.61 | 5.61 | 7.19 | 10.88 | 5.36 | 6.16 | Upgrade
|
Asset Turnover | 0.59 | 0.59 | 0.58 | 0.56 | 0.58 | 0.55 | Upgrade
|
Inventory Turnover | 2.29 | 2.29 | 2.24 | 2.36 | 2.67 | 2.32 | Upgrade
|
Quick Ratio | 1.03 | 1.03 | 1.05 | 0.82 | 1.02 | 1.46 | Upgrade
|
Current Ratio | 1.90 | 1.90 | 1.92 | 1.47 | 1.71 | 2.22 | Upgrade
|
Return on Equity (ROE) | 9.28% | 9.28% | 8.77% | 6.85% | 10.91% | 1.38% | Upgrade
|
Return on Assets (ROA) | 4.86% | 4.86% | 4.03% | 3.26% | 4.86% | 2.89% | Upgrade
|
Return on Capital (ROIC) | 5.80% | 5.80% | 4.78% | 3.83% | 5.60% | 3.35% | Upgrade
|
Return on Capital Employed (ROCE) | 8.60% | 8.60% | 7.40% | 6.20% | 9.00% | 5.00% | Upgrade
|
Earnings Yield | 3.96% | 3.24% | 3.41% | 2.10% | 2.34% | 0.18% | Upgrade
|
FCF Yield | 5.16% | 4.22% | 3.80% | 2.18% | 3.06% | 2.34% | Upgrade
|
Payout Ratio | 0.00% | - | - | - | - | 149.28% | Upgrade
|
Buyback Yield / Dilution | -1.51% | -1.51% | -0.60% | 1.17% | -0.02% | 0.43% | Upgrade
|
Total Shareholder Return | -1.51% | -1.51% | -0.60% | 1.17% | -0.02% | 0.43% | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.